# NYSTATIN AND TRIAMCINOLONE ACETONIDE
> **ANDA214181** · Abbreviated New Drug Application (Generic) · Sponsor: MACLEODS PHARMS LTD · Approved 2022-07-13
## Drug
- **FDA Application Number:** ANDA214181
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NYSTATIN AND TRIAMCINOLONE ACETONIDE
- **Generic name:** NYSTATIN AND TRIAMCINOLONE ACETONIDE
- **Active ingredients:** NYSTATIN; TRIAMCINOLONE ACETONIDE
- **Dosage form:** CREAM
- **Route:** TOPICAL
- **Marketing status:** Prescription
- **Sponsor:** MACLEODS PHARMS LTD
- **Manufacturer:** Macleods Pharmaceuticals Limited
- **First approval:** 2022-07-13
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214181)
---
*MORVS · CC0 1.0*